Ledger.Open graph →

SEC Form D · filed July 12, 2021

Frontier Medicines Corp

Offering

$88.5M

Sold

$88.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Jim Winkler · SOUTH SAN FRANCISCO, CAExec Othman Laraki · SOUTH SAN FRANCISCO, CADirector Chris Varma, Ph.D · SOUTH SAN FRANCISCO, CAExec · Director Johannes Hermann, Ph.D · SOUTH SAN FRANCISCO, CAExec Kevin Webster · SOUTH SAN FRANCISCO, CAExec Cameron Wheeler · SOUTH SAN FRANCISCO, CADirector Janwillem Naesens · SOUTH SAN FRANCISCO, CADirector Luke Evnin · SOUTH SAN FRANCISCO, CADirector Nigel D. Andrews · New York, NYExec · Director Michael C. Whisner · EVANSTON, ILDirector Thomas M. Hennigan · New York, NYExec Peter Bures · Vancouver, British Columbia, CanadaDirector Jeananne Hauswald · Vancouver, British Columbia, CanadaExec Richard Goldfarb · Vancouver, British Columbia, CanadaDirector David M. Battle, Jr · Atlanta, GAExec Leslie E. Bradford · New York, NYDirector Gregory Chow · SOUTH SAN FRANCISCO, CAExec Carlos, Jr. J. Rodriguez · Coral Gables, FLExec · Director David J. Buddemeyer · Coral Gables, FLDirector Carlos, Sr. J. Rodriguez · Coral Gables, FLExec Conner Galloway · FOSTER CITY, CADirector Alexander Valys · FOSTER CITY, CADirector Bob Fraser · Overland Park, KSDirector Gangadhara Ganapati · Palo Alto, CAExec Blair E. Richardson · Denver, COExec Gregory Chow · SOUTH SAN FRANCISCO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗